Insider at

04

Insider transactions

05
0 buys (P) 1 sells (S) Net: $-83,592 + 25 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

25 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
June 12, 2026 PBYI S 10b5-1 11,610 $7.20 $83,592 90,780 Direct -11.34% Disposed 31.1% (price as of 2026-10-05)
June 13, 2025 PBYI S 10b5-1 11,610 $3.40 $39,474 75,390 Direct -13.34% Disposed 177.6% (price as of 2026-10-05)
June 13, 2024 PBYI S 10b5-1 11,000 $3.37 $37,070 33,000 Direct -25.00% Disposed 180.1% (price as of 2026-10-05)
June 13, 2023 PBYI S 10b5-1 10,000 $3.45 $34,500 17,000 Direct -37.04% Disposed 173.6% (price as of 2026-10-05)
Feb. 11, 2021 VYGR S 10b5-1 3,186 $7.55 $24,054 45,894 Direct -6.49% Disposed -67.1% (price as of 2026-10-05)
Jan. 12, 2021 VYGR S 10b5-1 2,942 $8.62 $25,360 49,080 Direct -5.66% Disposed -71.2% (price as of 2026-10-05)
Jan. 21, 2020 VYGR S 10b5-1 3,128 $13.36 $41,790 24,522 Direct -11.31% Disposed -81.4% (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
June 5, 2024 JBIO Stock Option (Right to Buy) Common Stock (12,500) $18.90 June 4, 2034 12,500 Acquired
June 6, 2023 JBIO Stock Option (Right to Buy) Common Stock (12,500) $16.30 June 5, 2033 12,500 Acquired
June 21, 2022 JBIO Stock Option (Right to Buy) Common Stock (12,500) $12.26 June 20, 2032 12,500 Acquired
July 15, 2021 JBIO Stock Option (Right to Buy) Common Stock (25,000) $14.82 July 14, 2031 25,000 Acquired
July 15, 2021 PBYI STOCK OPTION (RIGHT TO BUY) COMMON STOCK (108,721) $8.19 July 14, 2031 108,721 Acquired
Feb. 16, 2021 VYGR Stock Option (Right to Buy) Common Stock (68,000) $7.33 Feb. 16, 2031 68,000 Acquired
Feb. 10, 2020 VYGR Stock Option (Right to Buy) Common Stock (55,000) $12.96 Feb. 10, 2030 55,000 Acquired
Jan. 11, 2019 VYGR Stock Option (Right to Buy) Common Stock (50,000) $9.10 Jan. 11, 2029 50,000 Acquired
Nov. 7, 2018 VYGR Stock Option (Right to Buy) Common Stock (45,000) $13.99 Nov. 7, 2028 45,000 Acquired
March 2, 2015 PODD Employee Stock Option (Right to Buy) Common Stock (14,607) $32.51 March 2, 2025 14,607 Acquired
Dec. 1, 2014 PODD Employee Stock Option (Right to Buy) Common Stock (11,148) $44.00 Dec. 1, 2024 11,148 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 9 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
June 15, 2018 VYGR Stock Option (Right to Buy)→ Common Stock (35,000) 35,000 Direct
June 15, 2018 VYGR Stock Option (Right to Buy)→ Common Stock (20,000) 20,000 Direct
Nov. 17, 2014 PODD Common Stock 22,342 Direct
Nov. 17, 2014 PODD Employee Stock Option (Right to Buy)→ Common Stock (5,000) 5,000 Direct
Nov. 17, 2014 PODD Employee Stock Option (Right to Buy)→ Common Stock (10,000) 10,000 Direct
Nov. 17, 2014 PODD Employee Stock Option (Right to Buy)→ Common Stock (10,000) 10,000 Direct
Nov. 17, 2014 PODD Employee Stock Option (Right to Buy)→ Common Stock (10,000) 10,000 Direct
Nov. 17, 2014 PODD Employee Stock Option (Right to Buy)→ Common Stock (6,000) 6,000 Direct
Nov. 17, 2014 PODD Employee Stock Option (Right to Buy)→ Common Stock (4,000) 4,000 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2015 $150,000 · · · · · $551,099 $1,201,099
2014 $242,596 · · · $79,600 · $7,800 $1,325,865

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.